Literature DB >> 26690931

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.

Ian K Komenaka1,2, Jesse N Nodora3, Lisa Madlensky3, Lisa M Winton4, Meredith A Heberer4, Richard B Schwab3, Jeffrey N Weitzel5, Maria Elena Martinez3.   

Abstract

Some communities and populations lack access to genetic cancer risk assessment (GCRA) and testing. This is particularly evident in safety-net institutions, which serve a large segment of low-income, uninsured individuals. We describe the experience of a safety-net clinic with limited resources in providing GCRA and BRCA1/2 testing. We compared the proportion and characteristics of high-risk women who were offered and underwent GCRA and genetic testing. We also provide a description of the mutation profile for affected women. All 125 patients who were offered GCRA accepted to undergo GCRA. Of these, 72 % had a breast cancer diagnosis, 70 % were Hispanic, 52.8 % were non-English speakers, and 66 % did not have health insurance. Eighty four (67 %) were offered genetic testing and 81 (96 %) agreed. Hispanic women, those with no medical insurance, and those with a family history of breast cancer were significantly more likely to undergo testing (p > 0.01). Twelve of 81 (15 %) patients were found to have deleterious mutations, seven BRCA1, and five BRCA2. Our experience shows that it is possible to offer GCRA and genetic testing even in the setting of limited resources for these services. This is important given that a large majority of the low-income women in our study agreed to undergo counseling and testing. Our experience could serve as a model for similar low-resource safety-net health settings.

Entities:  

Keywords:  Disparity; Genetic cancer risk assessment; Hispanic; Latina; Minority; Underinsured

Year:  2015        PMID: 26690931      PMCID: PMC4960024          DOI: 10.1007/s12687-015-0257-x

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  42 in total

1.  Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred.

Authors:  Anita Yeomans Kinney; Sara Ellis Simonsen; Bonnie Jeanne Baty; Diptasri Mandal; Susan L Neuhausen; Kate Seggar; Rich Holubkov; Ken Smith
Journal:  Am J Med Genet A       Date:  2006-04-15       Impact factor: 2.802

2.  Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.

Authors:  Reshma Jagsi; Kent A Griffith; Allison W Kurian; Monica Morrow; Ann S Hamilton; John J Graff; Steven J Katz; Sarah T Hawley
Journal:  J Clin Oncol       Date:  2015-04-06       Impact factor: 44.544

3.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

4.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Authors:  Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

5.  Reproductive factors, heterogeneity, and breast tumor subtypes in women of mexican descent.

Authors:  Maria Elena Martinez; Betsy C Wertheim; Loki Natarajan; Richard Schwab; Melissa Bondy; Adrian Daneri-Navarro; Maria Mercedes Meza-Montenegro; Luis Enrique Gutierrez-Millan; Abenaa Brewster; Ian K Komenaka; Patricia A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

Review 6.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

7.  Perceived cancer risk: why is it lower among nonwhites than whites?

Authors:  Heather Orom; Marc T Kiviniemi; Willie Underwood; Levi Ross; Vickie L Shavers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

8.  Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

9.  Hypothesized role of pregnancy hormones on HER2+ breast tumor development.

Authors:  Giovanna I Cruz; María Elena Martínez; Loki Natarajan; Betsy C Wertheim; Manuela Gago-Dominguez; Melissa Bondy; Adrian Daneri-Navarro; María Mercedes Meza-Montenegro; Luis Enrique Gutierrez-Millan; Abenaa Brewster; Pepper Schedin; Ian K Komenaka; J Esteban Castelao; Angel Carracedo; Carmen M Redondo; Patricia A Thompson
Journal:  Breast Cancer Res Treat       Date:  2012-11-08       Impact factor: 4.872

10.  NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

Authors:  Janice L Berliner; Angela Musial Fay; Shelly A Cummings; Brittany Burnett; Todd Tillmanns
Journal:  J Genet Couns       Date:  2012-11-28       Impact factor: 2.537

View more
  21 in total

1.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

2.  Translation and adaptation of skin cancer genomic risk education materials for implementation in primary care.

Authors:  Vivian M Rodríguez; Erika Robers; Kate Zielaskowski; C Javier González; Keith Hunley; Kimberly A Kaphingst; Dolores D Guest; Andrew Sussman; Kirsten A Meyer White; Matthew R Schwartz; Jennie Greb; Yvonne Talamantes; Jessica Bigney; Marianne Berwick; Jennifer L Hay
Journal:  J Community Genet       Date:  2016-12-06

3.  The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.

Authors:  Laura M Amendola; Jonathan S Berg; Carol R Horowitz; Frank Angelo; Jeannette T Bensen; Barbara B Biesecker; Leslie G Biesecker; Gregory M Cooper; Kelly East; Kelly Filipski; Stephanie M Fullerton; Bruce D Gelb; Katrina A B Goddard; Benyam Hailu; Ragan Hart; Kristen Hassmiller-Lich; Galen Joseph; Eimear E Kenny; Barbara A Koenig; Sara Knight; Pui-Yan Kwok; Katie L Lewis; Amy L McGuire; Mary E Norton; Jeffrey Ou; Donald W Parsons; Bradford C Powell; Neil Risch; Mimsie Robinson; Christine Rini; Sarah Scollon; Anne M Slavotinek; David L Veenstra; Melissa P Wasserstein; Benjamin S Wilfond; Lucia A Hindorff; Sharon E Plon; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2018-09-06       Impact factor: 11.025

4.  Seeing Beyond the Margins: Challenges to Informed Inclusion of Vulnerable Populations in Research.

Authors:  Sarah Gehlert; Jessica Mozersky
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

5.  Genomic Disparities in Breast Cancer Among Latinas.

Authors:  Filipa Lynce; Kristi D Graves; Lina Jandorf; Charite Ricker; Eida Castro; Laura Moreno; Bianca Augusto; Laura Fejerman; Susan T Vadaparampil
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

6.  Uptake of genetic testing for germline BRCA1/2 pathogenic variants in a predominantly Hispanic population.

Authors:  Julia E McGuinness; Meghna S Trivedi; Thomas Silverman; Awilda Marte; Jennie Mata; Rita Kukafka; Katherine D Crew
Journal:  Cancer Genet       Date:  2019-04-24

Review 7.  Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing.

Authors:  Deborah Cragun; Anita Y Kinney; Tuya Pal
Journal:  Expert Rev Mol Diagn       Date:  2016-12-13       Impact factor: 5.225

8.  A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings.

Authors:  Huma Q Rana; Sarah R Cochrane; Elaine Hiller; Ruth N Akindele; Callie M Nibecker; Ludmila A Svoboda; Angel M Cronin; Judy E Garber; Christopher S Lathan
Journal:  J Community Genet       Date:  2017-11-18

9.  Cancer genetic counseling communication with low-income Chinese immigrants.

Authors:  Janice Ka Yan Cheng; Claudia Guerra; Rena J Pasick; Dean Schillinger; Judith Luce; Galen Joseph
Journal:  J Community Genet       Date:  2017-12-01

10.  Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

Authors:  Randy Miles; Fei Wan; Tracy L Onega; Amanda Lenderink-Carpenter; Ellen S O'Meara; Weiwei Zhu; Louise M Henderson; Jennifer S Haas; Deirdre A Hill; Anna N A Tosteson; Karen J Wernli; Jennifer Alford-Teaster; Janie M Lee; Constance D Lehman; Christoph I Lee
Journal:  J Womens Health (Larchmt)       Date:  2018-01-17       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.